Morcellation of the Uterus: Is There Any Place?

Halaška, Michael; Gracia, Myriam; Laky, R; Zapardiel, Ignacio

doi:10.1007/s11912-020-00927-6

Cited by 4 publications

(2 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In some cases of enlarged uterine mass, morcellation is needed [7][8][9] and performed with the help of the in-bag (contained) morcellation [10]. For ~100 years manual morcellation was performed using a scalpel; while modern morcellation uses electromechanical morcellators that rapidly remove specimens, through the small laparoscopic incision, thus benefiting from the advantages of minimally invasive gynecologic surgery [11]. However, use of power morcellation in the peritoneal cavity was found to increase the risk of both benign and malignant cell dispersion [12,13].…”

Section: Introductionmentioning

confidence: 99%

An intrauterine cavity morcellator: A novel approach to high volume uterus morcellation. Ex-vivo study

et al. 2023

View full text Add to dashboard Cite

Objective Uterine size is one of the essential factors determining the feasibility of a minimally invasive gynecologic surgery approach. A traditional electromechanical morcellator is a well-known tool but not without flaws. We aim to assess feasibility and safety of a novel intrauterine power morcellation device for uterine size reduction to overcome these limitations during hysterectomy. Methods This single-arm, observational study was conducted in a single tertiary care medical center from April 2022 to July 2022. Feasibility and safety of a novel intrauterine morcellation device for uterine size reduction was tested in ten post-hysterectomy uteri (Ex-vivo). Measurements and main results Ten uteri were examined in this trial. No major complications occurred during the procedure. All ten (10) uteri were successfully reduced in size (size reduction range was between 9% to 54%). The average resection time using the Heracure Device was 4.3 minutes (range: 1min– 10min). Mean uterus weight reduction was 21%, with a mean circumference reduction of 25%. No leakage was observed from the outer surface of the uterus/serosa after the saline injection post-procedure examination. Conclusion In this novel experiment, we verified the feasibility and safety of the Heracure device for vaginal intra-uterine morcellation for uterine size reduction. This technique could enable rapid and easy removal of the uterus through the vaginal orifice. Clinical trial registration Name of the registry: ClinicalTrials.gov; Number Identifier: NCT05332132.

show abstract

Section: Introductionmentioning

confidence: 99%

An intrauterine cavity morcellator: A novel approach to high volume uterus morcellation. Ex-vivo study

et al. 2023

View full text Add to dashboard Cite

show abstract

“…In fact, the general issue of conflict of interest in fee‐for‐service healthcare, including surgery, is heavily ignored in the world of gynecology. There are several examples of gynecological surgery/endoscopic societies and surgeons recommending interventions, frequently funded by the industry that produces equipment/drugs for such interventions 50 , with little‐to‐no evidence regarding their effectiveness and safety, such as laparoscopic/robotic surgery for early‐stage cervical cancer 51 , power morcellation for fibroid removal 52 , transvaginal mesh for pelvic organ prolapse 53 and use of Essure for definitive contraception 54 . It is not infrequent for opinion leaders receiving financial support from the industry to ‘educate’ less experienced surgeons on how to perform these ‘safe and beneficial’ interventions and to publish uncontrolled studies with critical bias, systematic reviews of these studies 23 and recommendations/guidelines, perpetuating misinformation to a broader audience and exposing more patients to unproven interventions 55 .…”

Section: Introductionmentioning

confidence: 99%

ASRM Müllerian Anomalies Classification 2021: a critical review

Ludwin

Tudorache

Martins³

2022

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions

Żak

Zaremba

Rajtak

et al. 2022

Cancers

View full text Add to dashboard Cite

The distinguishing of uterine leiomyosarcomas (ULMS) and uterine leiomyomas (ULM) before the operation and histopathological evaluation of tissue is one of the current challenges for clinicians and researchers. Recently, a few new and innovative methods have been developed. However, researchers are trying to create different scales analyzing available parameters and to combine them with imaging methods with the aim of ULMs and ULM preoperative differentiation ULMs and ULM. Moreover, it has been observed that the technology, meaning machine learning models and artificial intelligence (AI), is entering the world of medicine, including gynecology. Therefore, we can predict the diagnosis not only through symptoms, laboratory tests or imaging methods, but also, we can base it on AI. What is the best option to differentiate ULM and ULMS preoperatively? In our review, we focus on the possible methods to diagnose uterine lesions effectively, including clinical signs and symptoms, laboratory tests, imaging methods, molecular aspects, available scales, and AI. In addition, considering costs and availability, we list the most promising methods to be implemented and investigated on a larger scale.

show abstract

Morcellation of the Uterus: Is There Any Place?

Cited by 4 publications

References 37 publications

An intrauterine cavity morcellator: A novel approach to high volume uterus morcellation. Ex-vivo study

An intrauterine cavity morcellator: A novel approach to high volume uterus morcellation. Ex-vivo study

ASRM Müllerian Anomalies Classification 2021: a critical review

Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions

Contact Info

Product

Resources

About